| Drug-eluting stents in peripheral vascular disease: eliminating restenosis. | |
| | |
MedLine Citation:
|
PMID: 14647877 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Transcatheter endovascular therapy for peripheral atherosclerotic disease has become more popular. In general, good results have been reported in focal aortoiliac disease. However, the long-term patency of angioplasty in longer, more distal lesions has been less satisfactory. Stenting has not been shown to improve long-term patency compared to angioplasty alone. Drug-eluting stents have shown promise in preventing coronary restenosis, and preliminary results in peripheral arterial disease are encouraging. This review article will discuss the current status of endovascular therapy of aortoiliac and femoropopliteal atherosclerotic disease, the theoretic and experimental basis for the use of drug-eluting stents, and the preliminary results in human studies. |
| | |
Authors:
|
Sharif H Ellozy; Alfio Carroccio |
Related Documents
:
|
11965827 - The economic burden of insulin resistance. 22243557 - Misdiagnosis in fibromyalgia: a multicentre study. 23355687 - Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges... 2195157 - Medical management of symptomatic peripheral vascular disease. 18944837 - Effect of sowing date, host cultivar, and race of fusarium oxysporum f. sp. ciceris on ... 21092187 - Fabry disease. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Mount Sinai journal of medicine, New York Volume: 70 ISSN: 0027-2507 ISO Abbreviation: Mt. Sinai J. Med. Publication Date: 2003 Nov |
Date Detail:
|
Created Date: 2003-12-03 Completed Date: 2004-01-29 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0241032 Medline TA: Mt Sinai J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 417-9 Citation Subset: IM |
Affiliation:
|
Department of Surgery, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA. sharif.ellozy@msnyuhealth.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiogenesis Inhibitors
/
administration & dosage Anti-Inflammatory Agents / administration & dosage Arterial Occlusive Diseases / prevention & control* Coronary Restenosis / prevention & control Drug Delivery Systems* Humans Immunosuppressive Agents / administration & dosage Peripheral Vascular Diseases / drug therapy* Prosthesis Design Recurrence* Sirolimus / administration & dosage Stents* Vascular Patency |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inhibitors; 0/Anti-Inflammatory Agents; 0/Immunosuppressive Agents; 53123-88-9/Sirolimus |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endovascular repair of diffuse atherosclerotic occlusive disease using stented grafts.
Next Document: Endovascular treatment of abdominal aortic aneurysms.